Separation & Purification

EBE says EC must do more on biodrug assessments

EBE says EC must do more on biodrug assessments

A biomanufacturing industry group has rejected the European Commission’s view that current regulations are flexible enough to apply to biopharmaceuticals and says more need to be done.

Repligen is looking at a massive expansion of its facilities

Repligen ups disposable chromatography column capacity

By Zachary Brennan

US biopharma company Repligen has completed a 9,000 square foot expansion of its facilities in Massachusetts to meet growing customer demand for disposable chromatography columns and warehousing.

Follow us

Product Innovations